Screening for Brain Aneurysms in Individuals with Family History

Risk Assessment

The American Heart Association recommends that individuals with a family history of brain aneurysm undergo screening, as the prevalence of intracranial aneurysm is increased, with ratios indicating an increased risk between 1.9% and 5.9% 1, 2
Risk factors that increase the likelihood of aneurysm detection in those with familial risk include older age, female sex, cigarette smoking, history of hypertension, higher lipid levels, and fasting glucose, as well as a family history of subarachnoid hemorrhage or aneurysm in two or more relatives 1, 2

For patients with one first-degree relative with a history of brain aneurysm, the American College of Cardiology recommends MRA or CTA screening, especially with additional risk factors, as first-degree relatives have approximately a 4% likelihood of harboring an unruptured intracranial aneurysm 3, 4, 2, 5
For patients with two or more first-degree relatives with a history of aneurysmal subarachnoid hemorrhage or unruptured intracranial aneurysm, screening is strongly recommended (Class I; Level of Evidence B) 3

The American Heart Association recommends MRA without contrast as the preferred initial screening method, with sensitivity rates of 69% to 93% for aneurysms greater than 3-5 mm, and it is non-invasive, avoiding radiation exposure 3, 6, 7
CT angiography is an acceptable alternative, demonstrating aneurysms as small as 2-3 mm with sensitivities of 77% to 97% 3, 4, 7

Modifiable risk factors should be addressed regardless of screening results, including smoking cessation, which is critical as smoking is a strong risk factor for aneurysm formation and rupture, and blood pressure control for those with hypertension 1, 2, 6
If an aneurysm is detected, treatment decisions should consider patient age, aneurysm size, location, and morphology, as well as risk factors for rupture 3, 8

The American Heart Association recommends screening for first-degree relatives of a patient who died from SAH if there are at least two affected first-degree relatives in the family, as this defines familial intracranial aneurysm syndrome with an 8-11% risk of harboring an unruptured aneurysm 9
The risk of harboring an unruptured aneurysm is approximately 4% for individuals with only one affected first-degree relative, compared to 1.8% in the general population, with a relative risk of 4.2 10, 11

Cost-effectiveness analysis shows that screening becomes unfavorable when the age at screening is ≥50 years, with an incremental cost-effectiveness ratio >$50,000 per QALY, or when only one first-degree relative is affected, with an incremental cost-effectiveness ratio of $56,500 per QALY 9

The American Heart Association suggests that screening may be reasonable if additional high-risk features are present, such as current smoking, hypertension, female sex, multiple aneurysms in the affected relative, or associated genetic conditions like autosomal dominant polycystic kidney disease or Type IV Ehlers-Danlos syndrome 9, 12
Screening may also be considered for patients under 50 years old with a strong preference for screening after informed discussion 9

The American Heart Association recommends against routine screening for a single elderly-onset SAH death, given the sporadic pattern, elderly onset, and unfavorable risk-benefit ratio, and instead suggests focusing on modifiable risk factors like smoking cessation and blood pressure control 9

The preferred modality for screening is MRA head without contrast, with a sensitivity of 95% and specificity of 89%, while CTA with contrast is an acceptable alternative with a sensitivity of 77-97% 11, 12

Routine screening of asymptomatic individuals in the general population is not supported by evidence and should not be performed (Class III, Level C). [13][14]15
The prevalence of unruptured intracranial aneurysms in the general population is ≈ 1.8%; cost‑effectiveness of population‑based screening has not been demonstrated. [13][16]
Individuals with environmental risk factors alone (e.g., smoking, alcohol use, hypertension) have a higher risk of subarachnoid hemorrhage but no proven increase in aneurysm prevalence; screening is not warranted in this group. [13][14]15

Screening should be offered because 10–11.5 % of ADPKD patients harbor an unruptured aneurysm, rising to ≈ 21 % when a first‑degree relative also has aneurysm history. 16
Aneurysmal subarachnoid hemorrhage occurs at a younger age in ADPKD patients compared with the general population. 16
Multiple studies have shown screening to be cost‑effective in this population. 16

Moyamoya disease, aortic dissection, bicuspid aortic valve, aortic aneurysm, and coarctation of the aorta. 16

Patients who have previously been treated for aneurysmal subarachnoid hemorrhage have a 1–2 % annual incidence of new aneurysm formation and should undergo periodic surveillance imaging. [13][14]17

Preferred initial screening modality because it is non‑invasive, avoids radiation and contrast, and is suitable for serial follow‑up. (Evidence level not explicitly cited; recommendation inferred from expert consensus.)

Acceptable alternative screening tool. Demonstrates > 90 % sensitivity and specificity; can detect aneurysms as small as 2–3 mm (sensitivity range 77–97 %). 16
Sensitivity declines for aneurysms < 3 mm and for lesions adjacent to bone. 16

Remains the gold standard when definitive diagnosis is required, but its invasiveness precludes routine screening use. [13][17]16
Procedure‑related complications: local catheter complications < 5 %; total neurological morbidity < 1 %; permanent neurological morbidity < 0.5 %. 18

Vessel loops and infundibular origins can mimic aneurysms on MRA, leading to false‑positive interpretations; expert neuroradiology review is essential. 16
Only a minority of unruptured aneurysms rupture, and all treatment modalities carry inherent risks. [13][17]
Psychological impact and quality‑of‑life consequences of an unruptured aneurysm diagnosis have not been adequately studied. [19][15]

Smoking cessation markedly reduces subarachnoid hemorrhage risk; former smokers have a lower relative risk than current smokers, with risk decreasing the longer the cessation period. [14][17]
Blood‑pressure control, moderation of alcohol intake, and patient education on warning symptoms (e.g., sudden “thunderclap” headache) are recommended for all individuals, irrespective of screening status. (Evidence level not explicitly cited.)